Fractional CMO & Strategic Advisor for Medical Device & Wound Care Companies
Stalled growth, portfolio complexity, post-acquisition chaos — Solved
PB MedTech partners with Series B through growth-stage medical device, diagnostics, and life sciences companies to drive revenue growth, commercial transformation, and operational clarity.
77%
Revenue Growth
800%
Quality Improvement
40%
Inventory Optimization
20+ Years
In Medical Device
Medical Device | Wound Care | Respiratory | Diagnostics | Gastroenterology | Dental | Surgical
You Need MoreThan A Consultant
Many fractional and advisory services assign junior resources and bill senior rates. PB MedTech works differently: every engagement is led personally by Phil Brewer, with 20+ years of hands-on medical device commercialization experience at companies ranging from startups to $2B global manufacturers.
✓ Series B through growth-stage life sciences companies
✓ CEOs and COOs who need commercial leadership without a full-time hire
✓ PE and VC portfolio companies navigating commercial inflection points
✓ Companies facing turnarounds, post-acquisition integration, or launch readiness
✓ Boards and operating partners who need a trusted commercial voice
How PB MedTech Engages
Fractional CMO
Ongoing strategic and operational marketing leadership, embedded with your team. Built for companies that need a CMO-level operator, not a project manager. Learn More
Advisory & Board Roles
Strategic counsel for CEOs, boards, and PE operating partners. Structured engagements designed for high-leverage access without full-time commitment. Learn More
Diagnostic & Launch Projects
Defined-scope engagements — Commercial Readiness Audits, Portfolio Turnaround Assessments, and Go-to-Market Launch Sprints. Each converts to a retainer at no onboarding cost. Learn More
Led By Phil Brewer
Phil has spent 20+ years building and rebuilding commercial engines for medical device, wound care and life sciences companies — including a 77% revenue growth turnaround at a $2B wound care company, an 800% reduction in product failures at a pre-acquisition gastroenterology diagnostic imaging company, and a $95M portfolio optimization at a medical and commercial oxygen supply manufacturer. He has led teams through product launches, post-acquisition integrations, and FDA-related commercial recovery.
PB MedTech was founded on a simple belief: the gap between great technology and commercial success is usually a strategy and execution problem — not a product problem.
Ready to talk through your commercial challenges?
No pitch decks, no intake forms. Just a direct conversation.